The CDC panel's recommendation of Pfizer's maternal vaccine was based on data from a phase three trial on nearly 7,400 participants. But mothers received the shot 24 to 36 weeks into their pregnancy in the trial, which is a wider period than the approved dosing time frame. During the...
The new guidance recommends that everyone over the age of 75 get the RSV vaccine, as well as anyone aged 60 to 74 who is “at increased risk of severe RSV.” Prior to this, the CDC recommended that everyone over the age of 60 have the option of receiving an RSV vaccine dose. “This...
此次CDC公布的数据通过新疫苗监测网络(New Vaccine Surveillance Network)评估所得,内容涉及2023年10月1日至2024年2月29日间,首个RSV季节中Beyfortus预防RSV相关住院治疗有效性的分析。分析显示,在699名因急性呼吸道疾病住院的婴儿中,有59名(8%)在症状出现≥7天前接受了Beyfortus。Beyfortus对于预防RSV相关住院治疗的...
The CDC has recommended Pfizer's maternal RSVpreF vaccine (Abrysvo) to protect newborns from severe respiratory syncytial virus (RSV) illness, according to a news release. Approved by the FDA in August 2023, the vaccine has been shown to reduce the risk of RSV hospitalization by 57% for ...
此次CDC公布的数据通过新疫苗监测网络(New Vaccine Surveillance Network)评估所得,内容涉及2023年10月1日至2024年2月29日间,首个RSV季节中Beyfortus预防RSV相关住院治疗有效性的分析。分析显示,在699名因急性呼吸道疾病住院的婴儿中,有59名(8%)在症状出现≥7天前接受了Beyfortus。Beyfortus对于预防RSV相关住院治疗的...
CDC recommends 1st maternal RSV vaccine The vaccine is recommended for pregnant women in their third trimester to protect newborn babies. September 25, 2023 Additional Live Streams Live ABC News Live Live Tracking rain and snow in the West, warmer temperatures moving East...
Currently there are several vaccines being developed. One RSV vaccine is currently being tested in Europe. None are routinely available to immunize vulnerable populations as of November 2022. REFERENCES(参考文献) 1. AAP,Updated AAP guidance recommends longer...
Currently there are several vaccines being developed. One RSV vaccine is currently being tested in Europe. None are routinely available to immunize vulnerable populations as of November 2022. REFERENCES(参考文献) 1. AAP,Updated AAP guidance recommends longer breastfeeding due to benefits, June 2022,...
图片来源:《Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults》-NEJM RSV疫苗的商业未来 目前市面上已上市的两款疫苗均为重组蛋白疫苗,也就是疫苗中并没有“真病毒”,而是将RSV病毒上的“F”蛋白作为抗原,更准确的说,是与人体细胞融合之前的“F”蛋白。这是一种非常巧妙的设计,可以...
来源:Vaccine前研 ✎我国科学家发现新冠病毒新血清型,为研发广谱新冠疫苗提供依据 中国科学院微生物研究所的团队发现新冠病毒变异株BA.2.86已演化成新血清型,这一发现对未来的疫苗和抗体研发具有重要意义。研究通过小鼠血清交叉中和分析,确定BA.2.86与现有XBB变异株的抗原性有明显区别,暗示基于XBB的疫苗可能无法充分抵...